NIMG-26. DIAGNOSIS OF PSEUDOPROGRESSION FOLLOWING RADIOTHERAPY PLUS LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS USING FET PET

BACKGROUND: The CeTeG/NOA-09 trial demonstrated a significant survival benefit of radiotherapy plus lomustine-temozolomide chemotherapy in glioblastoma patients with methylated O(6)-methylguanine-DNA-methyltransferase (MGMT) promoter compared to standard temozolomide chemoradiation (1). However, dat...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Werner, Jan-Michael, Ceccon, Garry, Weller, Johannes, Schaub, Christina, Tscherpel, Caroline, Lohmann, Philipp, Bauer, Elena, Schäfer, Niklas, Stoffels, Gabriele, Kabbasch, Christoph, Baues, Christian, Marnitz, Simone, Fink, Gereon R, Langen, Karl-Josef, Herrlinger, Ulrich, Galldiks, Norbert
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2020
Onderwerpen:
Neuroimaging
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651124/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.639
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items